Assessing Spectral Fidelity: Dual-Source Photon-counting detector CT in Calcium Imaging
Source PublicationInvestigative Radiology
Primary AuthorsRajendran, Ferrero, Shanblatt et al.

This investigation evaluates whether a dual-source configuration improves material decomposition in photon-counting detector CT systems. The authors posit that adding a tin filter to the B-subsystem enhances spectral separation. While the technical metrics appear robust within the controlled environment of water phantoms, the clinical applicability rests on a very narrow sample size.
Methodology and Phantom Analysis
The core experiment involved scanning calcium inserts of varying concentrations (100–300 mg/cc) within water phantoms ranging from 30 to 50 cm in lateral diameter. Researchers utilised the NAEOTOM Alpha for both single-source and dual-source photon-counting protocols, comparing these against a standard dual-source energy-integrating detector (EID) system. The primary metric, spectral separation, was quantified via the dual-energy ratio (DER) and the mean absolute percent error (MAPE) of calcium mass density.
Spectral Performance of Photon-counting detector CT
In the phantom trials, the dual-source mode (specifically at 70/Sn150 kV) yielded the highest mean DER for lower concentration calcium inserts. Furthermore, the MAPE for calcium mass density remained consistently lower in the dual-source photon-counting group (max 1.44%) compared to single-source (3.97%) or EID systems (3.68%). These figures indicate a higher technical precision in material decomposition under idealised conditions. The system effectively reduced the variance in mass density estimation across different phantom sizes.
Clinical Feasibility and Limitations
To test real-world translation, the team scanned four patients. Reconstructed maps aimed to visualise bone oedema. Qualitatively, these images appeared comparable to MRI and offered potentially sharper definition than EID-CT, specifically regarding fracture sites. However, with an N of 4, these findings are anecdotal. They serve as a proof-of-concept rather than definitive clinical validation. The data supports the technical hypothesis regarding spectral separation, yet broader trials are required to confirm diagnostic utility in complex biological environments.